Phase 1/2 open-label trial to assess the safety and preliminary efficacy of (177)Lu-OPS201 as peptide receptor radionuclide therapy in patients with somatostatin receptor-positive, progressive neuroendocrine tumors Meeting Abstract
| Authors: | Nicolas, G.; Bodei, L.; Baum, R.; Herrmann, K.; Lassmann, M.; Hicks, R.; Navalkissoor, S.; Haug, A.; Oberwittler, H.; Wang, T.; Wild, D. |
| Abstract Title: | Phase 1/2 open-label trial to assess the safety and preliminary efficacy of (177)Lu-OPS201 as peptide receptor radionuclide therapy in patients with somatostatin receptor-positive, progressive neuroendocrine tumors |
| Meeting Title: | 10th Annual Meeting of the North American Neuroendocrine Tumor Society (NANETS) |
| Journal Title: | Pancreas |
| Volume: | 47 |
| Issue: | 3 |
| Meeting Dates: | 2017 Oct 19-21 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0885-3177 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2018-03-01 |
| Start Page: | 349 |
| Language: | English |
| ACCESSION: | WOS:000426086300079 |
| PROVIDER: | wos |
| DOI: | 10.1097/MPA.0000000000000997 |
| Notes: | Meeting Abstract -- Source: Wos |
